{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1151.21","meta":{"versionId":"3","lastUpdated":"2017-02-16T01:00:02.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Oregon Urology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-02-16"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-02-16"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1151.21"}],"version":"20170216","name":"CalcineurinInhibitorsForPatientsReceivingUrologyCare","title":"Calcineurin inhibitors for patients receiving Urology Care","status":"active","experimental":false,"date":"2017-02-16T01:00:02-05:00","publisher":"Oregon Urology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Calcineurin inhibitors for patients receiving urology care.),(Data Element Scope: This data element is to define immunosuppresssive therapy in patients receiving urology care.),(Inclusion Criteria: Patients on calcineruin inhibitors.),(Exclusion Criteria: Patients not on calcineurin inhibitors.)","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"416587008","display":"Calcineurin inhibitor (product)"}]}]},"expansion":{"identifier":"urn:uuid:4ffce277-e336-4510-9324-ba6f69beae7f","timestamp":"2023-12-10T22:29:36-05:00","total":1,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"416587008","display":"Product containing calcineurin inhibitor (product)"}]}}